Sign Out
Xospata is indicated for the treatment of patients who have relapsed or refractory acute myeloid leukaemia (AML) with FMS-like tyrosine kinase 3 (FLT3) mutations.
Select patients based on a positive FLT3 mutation test.
UserName
Profession Email
Profession Email
Continue with Google